Sentara Molecular Laboratory chosen for National Cancer Institute treatment trials
August 27, 2025
August 27, 2025
NORFOLK, Virginia, Aug. 27 [Category: BizHospital] -- Sentara Healthcare posted the following news:
* * *
Sentara Molecular Laboratory chosen for National Cancer Institute treatment trials
*
The National Cancer Institute (NCI), part of the National Institutes of Health, has designated the Sentara Molecular Diagnostics Laboratory at Sentara Norfolk General Hospital for participation in the nationwide ComboMATCH cancer trial.
ComboM . . .
* * *
Sentara Molecular Laboratory chosen for National Cancer Institute treatment trials
*
The National Cancer Institute (NCI), part of the National Institutes of Health, has designated the Sentara Molecular Diagnostics Laboratory at Sentara Norfolk General Hospital for participation in the nationwide ComboMATCH cancer trial.
ComboM . . .